Stuart Levitz

Dr. Stuart Levitz is a Professor of Medicine at UMass Chan Medical School, affiliated with the T.H. Chan School of Medicine and multiple graduate programs at Morningside Graduate School of Biomedical Sciences. His research focuses on fungal immunology, vaccine development, and the pathogenesis of infections like cryptococcosis and aspergillosis. Dr. Levitz holds leadership roles in departments such as Medicine, Microbiology, and Immunology and Microbiology Program.

He has extensive education and training, including a BA and MD from New York University. His work spans over 200 publications, emphasizing innovative vaccine strategies using glucan particles and understanding host immune responses to fungal pathogens. Key areas include T cell-mediated immunity, diagnostic tools for cryptococcal infections, and the molecular mechanisms of fungal evasion. His contributions have advanced therapeutic approaches for fungal diseases, particularly in immunocompromised populations.

Dr. Levitz collaborates on global health initiatives, such as improving diagnostics in Liberia and studying emerging fungal threats like Candida auris. His research integrates clinical, immunological, and genomic perspectives to combat fungal infections. Despite no explicitly listed awards or grants, his prolific output underscores his impact in the field.